BungardTJArcherSLHamiltonT, et al. Bringing the benefits of anticoagulation management services to the community: Alberta program may serve as a model of care. Can Pharm J (Ott)2006;139(2):58-63.
2.
HolbrookASchulmanSWittDM, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guideline. Chest2012;141(2)(Suppl):e152S-84S.
ShalevVRogowskiOShimronO, et al. The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation. Thromb Res2007;120(2):201-6.
5.
SchulmanSParplaSStewartC, et al. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios. Ann Intern Med2011;155:653-9.
6.
LidstoneVJanesSStrossP. INR: intervals of measurement can safely extend to 14 weeks. Clin Lab Haematol2000;22(5):291-3.
7.
PengoVBarberoFBiasioloA, et al. A comparison between six and four week intervals in surveillance of oral anticoagulation treatment. Am J Clin Pathol2003;120:944-7.
